Related Experiment Videos
Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis.
Lucia C Petito1, Xiaoning Huang2, C Noel Bairey Merz3
1Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Journal of the American Heart Association
|July 3, 2026
Summary
Adverse pregnancy outcomes (APOs) contribute to hypertension disparities in Black women. Addressing racial gaps in APOs could significantly reduce hypertension differences between Black and White individuals.
Area of Science:
- Reproductive Health
- Cardiovascular Health
- Health Disparities
Background:
- Adverse pregnancy outcomes (APOs) are linked to increased hypertension risk.
- Black women face higher rates of both APOs and hypertension compared to White women.
- The role of APOs in contributing to Black-White hypertension disparities is not well understood.
Purpose of the Study:
- To investigate whether APOs mediate the racial disparity in hypertension.
- To quantify the potential reduction in hypertension disparities if APO disparities were eliminated.
Main Methods:
- Prospective recruitment of nulliparous individuals in the nuMoM2b-HHS study across 8 US centers.
- Follow-up assessments 2-7 years postpartum to determine incident hypertension.
- Analysis using targeted maximum likelihood estimation to model the impact of eliminating APO disparities on Black-White hypertension differences.
Main Results:
- Higher incidence of APOs (hypertensive disorders of pregnancy, preterm birth, small-for-gestational age) observed in Black versus White participants.
- Incident hypertension was significantly higher in Black versus White individuals postpartum.
- Eliminating racial disparities in APOs could decrease the Black-White hypertension disparity by 13.9% to 18.2%.
Conclusions:
- Adverse pregnancy outcomes partially mediate the observed Black-White differences in hypertension.
- APOs represent a potential pregnancy-specific pathway contributing to racial disparities in hypertension.
- Targeting disparities in adverse pregnancy outcomes may help reduce long-term hypertension risk differences.
Related Concept Videos
Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Factors affecting Blood pressure
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...